Zobrazeno 1 - 10 of 242 pro vyhledávání: '"Regagnon, C."'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Editorial & Opinion
Increase over time of antibody levels 3 months after a booster dose as an indication of better protection against Omicron infection.
Autor: Bingula R; UMR UNH, ECREIN, Immunology Laboratory, Faculty of Medicine, Clermont Auvergne University, Clermont-Ferrand, France., Chabrolles H; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France.; CNRS UMR 6023, LMGE, Clermont Auvergne University, Clermont-Ferrand, France., Bonnet B; UMR UNH, ECREIN, Immunology Laboratory, Faculty of Medicine, Clermont Auvergne University, Clermont-Ferrand, France.; Immunology Department, Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Clermont-Ferrand, France., Archimbaud C; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France.; CNRS UMR 6023, LMGE, Clermont Auvergne University, Clermont-Ferrand, France., Brebion A; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France., Cosme J; Immunology Department, Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Clermont-Ferrand, France., Ollier A; Clinical Research and Innovation Direction, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand) 3 IHP, Clermont-Ferrand, France., Dutheil F; Preventive and Occupational Medicine, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), Clermont-Ferrand, France.; CNRS, LaPSCo Physiological and Psychosocial Stress, Clermont Auvergne University, Clermont-Ferrand, France., Junda M; Immunology Department, Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Clermont-Ferrand, France., Mirand A; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France.; CNRS UMR 6023, LMGE, Clermont Auvergne University, Clermont-Ferrand, France., Regagnon C; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France.; CNRS UMR 6023, LMGE, Clermont Auvergne University, Clermont-Ferrand, France., Vidal M; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France.; CNRS UMR 6023, LMGE, Clermont Auvergne University, Clermont-Ferrand, France., Henquell C; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France.; CNRS UMR 6023, LMGE, Clermont Auvergne University, Clermont-Ferrand, France., Evrard B; UMR UNH, ECREIN, Immunology Laboratory, Faculty of Medicine, Clermont Auvergne University, Clermont-Ferrand, France.; Immunology Department, Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Clermont-Ferrand, France.
Publikováno v: Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2184176.
Zobrazit plný text záznamu
4
Akademický článek
Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing.
Autor: Combes P; CHU Clermont-Ferrand, pôle BMAP, F-63003 Clermont-Ferrand, France., Bisseux M; CHU Clermont-Ferrand, 3IHP, Virology Laboratory, National Reference Centre for Enteroviruses and parechoviruses-associated laboratory, F-63003 Clermont-Ferrand, France; Université Clermont Auvergne, CNRS 6023-LMGE, EPIE, F-63001 Clermont-Ferrand, France., Bal A; GenEPII Sequencing Platform, Institut des Agents Infectieux, Hospices Civils de Lyon, F-69004 Lyon, France; CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France., Marin P; CHU Clermont-Ferrand, 3IHP, Virology Laboratory, National Reference Centre for Enteroviruses and parechoviruses-associated laboratory, F-63003 Clermont-Ferrand, France., Latour J; CHU de Toulouse, Virology Laboratory, F-31300 Toulouse, France., Archimbaud C; CHU Clermont-Ferrand, 3IHP, Virology Laboratory, National Reference Centre for Enteroviruses and parechoviruses-associated laboratory, F-63003 Clermont-Ferrand, France; Université Clermont Auvergne, CNRS 6023-LMGE, EPIE, F-63001 Clermont-Ferrand, France., Brebion A; CHU Clermont-Ferrand, 3IHP, Virology Laboratory, National Reference Centre for Enteroviruses and parechoviruses-associated laboratory, F-63003 Clermont-Ferrand, France., Chabrolles H; CHU Clermont-Ferrand, 3IHP, Virology Laboratory, National Reference Centre for Enteroviruses and parechoviruses-associated laboratory, F-63003 Clermont-Ferrand, France; Université Clermont Auvergne, CNRS 6023-LMGE, EPIE, F-63001 Clermont-Ferrand, France., Regagnon C; CHU Clermont-Ferrand, 3IHP, Virology Laboratory, National Reference Centre for Enteroviruses and parechoviruses-associated laboratory, F-63003 Clermont-Ferrand, France., Lafolie J; CH Vichy, Laboratory Department, F-03000 Vichy, France., Destras G; GenEPII Sequencing Platform, Institut des Agents Infectieux, Hospices Civils de Lyon, F-69004 Lyon, France; CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France., Simon B; GenEPII Sequencing Platform, Institut des Agents Infectieux, Hospices Civils de Lyon, F-69004 Lyon, France; CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France., Izopet J; CHU de Toulouse, Virology Laboratory, F-31300 Toulouse, France; INFINITY, INSERM UMR291-CNRS UMR5051-Toulouse University, F-31300 Toulouse, France; Université Toulouse III Paul Sabatier, F-31300 Toulouse, France., Laurence Josset; GenEPII Sequencing Platform, Institut des Agents Infectieux, Hospices Civils de Lyon, F-69004 Lyon, France; CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France., Henquell C; CHU Clermont-Ferrand, 3IHP, Virology Laboratory, National Reference Centre for Enteroviruses and parechoviruses-associated laboratory, F-63003 Clermont-Ferrand, France; Université Clermont Auvergne, CNRS 6023-LMGE, EPIE, F-63001 Clermont-Ferrand, France., Mirand A; CHU Clermont-Ferrand, 3IHP, Virology Laboratory, National Reference Centre for Enteroviruses and parechoviruses-associated laboratory, F-63003 Clermont-Ferrand, France; Université Clermont Auvergne, CNRS 6023-LMGE, EPIE, F-63001 Clermont-Ferrand, France. Electronic address: amirand@chu-clermontferrand.fr.
Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2022 Nov; Vol. 28 (11), pp. 1503.e5-1503.e8. Date of Electronic Publication: 2022 Jul 02.
Zobrazit plný text záznamu
5
Akademický článek
Infections à entérovirus et parechovirus : de mieux en mieux documentées
Autor: Mirand, A., Henquell, C., Archimbaud, C., Chambon, M., Regagnon, C., Brebion, A., Bailly, J.-L., Peigue-Lafeuille, H.
Publikováno v: In Archives de pédiatrie May 2013 20(5) Supplement 1:H157-H158
Zobrazit plný text záznamu
6
Report
Comparative T and B immune responses of four different anti-COVID-19 vaccine strategies 6 months after vaccination.
Autor: Bonnet B; Immunology Department, CHU Clermont-Ferrand, Service d'immunologie, Clermont-Ferrrand, Clermont-Ferrand F-63000, France; Clermont Auvergne University, UMR1019 UNH, ECREIN, Clermont-Ferrand, France. Electronic address: b_bonnet@chu-clermontferrand.fr., Chabrolles H; CHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France; Clermont Auvergne University, CNRS UMR 6023, LMGE, Clermont-Ferrand, France., Archimbaud C; CHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France; Clermont Auvergne University, CNRS UMR 6023, LMGE, Clermont-Ferrand, France., Brebion A; CHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France., Godignon M; Immunology Department, CHU Clermont-Ferrand, Service d'immunologie, Clermont-Ferrrand, Clermont-Ferrand F-63000, France., Dutheil F; CHU Clermont-Ferrand, Preventive and Occupational Medicine, Clermont-Ferrand, France; Clermont Auvergne University, CNRS, LaPSCo Physiological and Psychosocial Stress, Clermont-Ferrand, France., Lambert C; CHU Clermont-Ferrand, DRCI, Biostatistics unit, Clermont-Ferrand, France., Cosme J; Immunology Department, CHU Clermont-Ferrand, Service d'immunologie, Clermont-Ferrrand, Clermont-Ferrand F-63000, France., Mirand A; CHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France; Clermont Auvergne University, CNRS UMR 6023, LMGE, Clermont-Ferrand, France., Ollier A; CHU Clermont-Ferrand, 3 IHP, Clinical Research and Innovation Direction, Clermont-Ferrand, France., Pereira B; CHU Clermont-Ferrand, DRCI, Biostatistics unit, Clermont-Ferrand, France., Regagnon C; CHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France., Vidal M; Infectious Diseases Department, CHU Clermont-Ferrand, 3 IHP, Clermont-Ferrand, France., Evrard B; Immunology Department, CHU Clermont-Ferrand, Service d'immunologie, Clermont-Ferrrand, Clermont-Ferrand F-63000, France; Clermont Auvergne University, UMR1019 UNH, ECREIN, Clermont-Ferrand, France., Henquell C; CHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France; Clermont Auvergne University, CNRS UMR 6023, LMGE, Clermont-Ferrand, France.
Publikováno v: The Journal of infection [J Infect] 2022 May; Vol. 84 (5), pp. e45-e47. Date of Electronic Publication: 2022 Mar 09.
Zobrazit plný text záznamu
7
Akademický článek
Decline of Humoral and Cellular Immune Responses Against SARS-CoV-2 6 Months After Full BNT162b2 Vaccination in Hospital Healthcare Workers.
Autor: Bonnet B; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Immunology Department, Clermont-Ferrand, France.; Clermont Auvergne University, UMR UNH, ECREIN, Clermont-Ferrand, France., Chabrolles H; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), 3IHP, Virology Department, Clermont-Ferrand, France.; Clermont Auvergne University, CNRS UMR, LMGE, Clermont-Ferrand, France., Archimbaud C; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), 3IHP, Virology Department, Clermont-Ferrand, France.; Clermont Auvergne University, CNRS UMR, LMGE, Clermont-Ferrand, France., Brebion A; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), 3IHP, Virology Department, Clermont-Ferrand, France., Cosme J; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Immunology Department, Clermont-Ferrand, France., Dutheil F; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Preventive and Occupational Medicine, Clermont-Ferrand, France.; Clermont Auvergne University, CNRS, LaPSCo Physiological and Psychosocial Stress, Clermont-Ferrand, France., Lambert C; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Clinical Research and Innovation Direction (DRCI), Biostatistics Unit, Clermont-Ferrand, France., Junda M; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Immunology Department, Clermont-Ferrand, France., Mirand A; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), 3IHP, Virology Department, Clermont-Ferrand, France.; Clermont Auvergne University, CNRS UMR, LMGE, Clermont-Ferrand, France., Ollier A; Clermont-Ferrand University Hospital (CHU Clermont Ferrand) 3 IHP, Clinical Research and Innovation Direction, Clermont-Ferrand, France., Pereira B; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Clinical Research and Innovation Direction (DRCI), Biostatistics Unit, Clermont-Ferrand, France., Regagnon C; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), 3IHP, Virology Department, Clermont-Ferrand, France., Vidal M; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), 3 IHP, Infectious Diseases Department, Clermont-Ferrand, France., Evrard B; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Immunology Department, Clermont-Ferrand, France.; Clermont Auvergne University, UMR UNH, ECREIN, Clermont-Ferrand, France., Henquell C; Clermont-Ferrand University Hospital (CHU Clermont Ferrand), 3IHP, Virology Department, Clermont-Ferrand, France.; Clermont Auvergne University, CNRS UMR, LMGE, Clermont-Ferrand, France.
Publikováno v: Frontiers in immunology [Front Immunol] 2022 Mar 02; Vol. 13, pp. 842912. Date of Electronic Publication: 2022 Mar 02 (Print Publication: 2022).
Zobrazit plný text záznamu
8
Akademický článek
A large-scale outbreak of hand, foot and mouth disease, France, as at 28 September 2021.
Autor: Mirand A; CHU Clermont-Ferrand, Laboratoire de Virologie, Centre National de Référence des entérovirus et parechovirus - Laboratoire Associé, Clermont-Ferrand, France.; Université d'Auvergne, LMGE UMR CNRS 6023 Equipe EPIE - Epidémiologie et physiopathologie des infections à entérovirus, Faculté de Médecine, Clermont-Ferrand, France., Cohen R; Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), Créteil, France., Bisseux M; CHU Clermont-Ferrand, Laboratoire de Virologie, Centre National de Référence des entérovirus et parechovirus - Laboratoire Associé, Clermont-Ferrand, France.; Université d'Auvergne, LMGE UMR CNRS 6023 Equipe EPIE - Epidémiologie et physiopathologie des infections à entérovirus, Faculté de Médecine, Clermont-Ferrand, France., Tomba S; Université d'Auvergne, LMGE UMR CNRS 6023 Equipe EPIE - Epidémiologie et physiopathologie des infections à entérovirus, Faculté de Médecine, Clermont-Ferrand, France., Sellem FC; Association Française de Pédiatrie Ambulatoire (AFPA), Orléans, France., Gelbert N; Association Française de Pédiatrie Ambulatoire (AFPA), Orléans, France., Béchet S; Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), Créteil, France., Frandji B; CompuGroup Medical France, Nanterre, France., Archimbaud C; CHU Clermont-Ferrand, Laboratoire de Virologie, Centre National de Référence des entérovirus et parechovirus - Laboratoire Associé, Clermont-Ferrand, France.; Université d'Auvergne, LMGE UMR CNRS 6023 Equipe EPIE - Epidémiologie et physiopathologie des infections à entérovirus, Faculté de Médecine, Clermont-Ferrand, France., Brebion A; CHU Clermont-Ferrand, Laboratoire de Virologie, Centre National de Référence des entérovirus et parechovirus - Laboratoire Associé, Clermont-Ferrand, France., Chabrolles H; CHU Clermont-Ferrand, Laboratoire de Virologie, Centre National de Référence des entérovirus et parechovirus - Laboratoire Associé, Clermont-Ferrand, France.; Université d'Auvergne, LMGE UMR CNRS 6023 Equipe EPIE - Epidémiologie et physiopathologie des infections à entérovirus, Faculté de Médecine, Clermont-Ferrand, France., Regagnon C; CHU Clermont-Ferrand, Laboratoire de Virologie, Centre National de Référence des entérovirus et parechovirus - Laboratoire Associé, Clermont-Ferrand, France., Levy C; Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), Créteil, France., Bailly JL; CHU Clermont-Ferrand, Laboratoire de Virologie, Centre National de Référence des entérovirus et parechovirus - Laboratoire Associé, Clermont-Ferrand, France.; Université d'Auvergne, LMGE UMR CNRS 6023 Equipe EPIE - Epidémiologie et physiopathologie des infections à entérovirus, Faculté de Médecine, Clermont-Ferrand, France., Henquell C; CHU Clermont-Ferrand, Laboratoire de Virologie, Centre National de Référence des entérovirus et parechovirus - Laboratoire Associé, Clermont-Ferrand, France.; Université d'Auvergne, LMGE UMR CNRS 6023 Equipe EPIE - Epidémiologie et physiopathologie des infections à entérovirus, Faculté de Médecine, Clermont-Ferrand, France.
Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2021 Oct; Vol. 26 (43).
Zobrazit plný text záznamu
9
Akademický článek
Human herpesvirus 6 infection after autologous stem cell transplantation: A multicenter prospective study in adult patients.
Autor: Balsat M; Hematology Department, Institut de Cancérologie Lucien Neuwirth, 108, bis avenue Albert Raymond, 42270 Saint-Priest-en-Jarez, France; Hematology Department, Hospices Civils de Lyon, Pavillon Marcel Bérard, Centre Hospitalier Lyon Sud, 165 chemin du Grand Revoyet, Centre Hospitalier Lyon Sud, 69495 Pierre Bénite, France. Electronic address: marie.balsat@chu-lyon.fr., Pillet S; CHU de Saint-Etienne, Laboratory of Infectious Agents and Hygiene, avenue Albert Raymond, 42270 Saint-Priest-en-jarez, France., Tavernier E; Hematology Department, Institut de Cancérologie Lucien Neuwirth, 108, bis avenue Albert Raymond, 42270 Saint-Priest-en-Jarez, France., Cacheux V; Hematology Department, CHU Clermont-Ferrand, 1, rue Lucie Aubrac, 63100 Clermont-Ferrand, France., Escuret V; Hospices Civils de Lyon, GHN, Laboratoire de Virologie F-69317, Lyon, France., Moluçon-Chabrot C; Hematology Department, CHU Clermont-Ferrand, 1, rue Lucie Aubrac, 63100 Clermont-Ferrand, France., Augeul-Meunier K; Hematology Department, Institut de Cancérologie Lucien Neuwirth, 108, bis avenue Albert Raymond, 42270 Saint-Priest-en-Jarez, France., Mirand A; CHU Clermont-Ferrand, Laboratory of Virology, F-63003 Clermont-Ferrand, France., Regagnon C; CHU Clermont-Ferrand, Laboratory of Virology, F-63003 Clermont-Ferrand, France., Tinquaut F; Institut de Cancérologie Lucien Neuwirth, Centre Hygée, Chemin de la Marandière, 42270 Saint-Priest-en-Jarez, France., Bousser V; Institut de Cancérologie Lucien Neuwirth, Centre Hygée, Chemin de la Marandière, 42270 Saint-Priest-en-Jarez, France., Oriol M; Institut de Cancérologie Lucien Neuwirth, Centre Hygée, Chemin de la Marandière, 42270 Saint-Priest-en-Jarez, France., Guyotat D; Hematology Department, Institut de Cancérologie Lucien Neuwirth, 108, bis avenue Albert Raymond, 42270 Saint-Priest-en-Jarez, France., Salles G; Hematology Department, Hospices Civils de Lyon, Pavillon Marcel Bérard, Centre Hospitalier Lyon Sud, 165 chemin du Grand Revoyet, Centre Hospitalier Lyon Sud, 69495 Pierre Bénite, France., Bay JO; Hospices Civils de Lyon, GHN, Laboratoire de Virologie F-69317, Lyon, France., Pozzetto B; CHU de Saint-Etienne, Laboratory of Infectious Agents and Hygiene, avenue Albert Raymond, 42270 Saint-Priest-en-jarez, France., Cornillon J; Hematology Department, Institut de Cancérologie Lucien Neuwirth, 108, bis avenue Albert Raymond, 42270 Saint-Priest-en-Jarez, France.
Publikováno v: The Journal of infection [J Infect] 2019 Jul; Vol. 79 (1), pp. 36-42. Date of Electronic Publication: 2019 May 07.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje